We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

86 hedge funds and large institutions have $177M invested in ChemoCentryx, Inc. in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 24 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 24

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2% less funds holding

Funds holding: 8886 (-2)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

23% less capital invested

Capital invested by funds: $228M → $177M (-$51.5M)

Holders
86
Holders Change
-2
Holders Change %
-2.27%
% of All Funds
2.14%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
31
Reduced
24
Closed
14
Calls
$201K
Puts
Net Calls
+$201K
Net Calls Change
+$304K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$681K -$200K -24,116 -21%
SO
27
STRS Ohio
Ohio
$638K +$87.3K +10,500 +14%
BTS
28
BB&T Securities
Virginia
$619K
ZIM
29
Zacks Investment Management
Illinois
$589K +$660K +79,349 New
Russell Investments Group
30
Russell Investments Group
United Kingdom
$578K -$318K -38,215 -33%
ADEF
31
Adams Diversified Equity Fund
Maryland
$533K -$21.6K -2,600 -3%
Ohio Public Employees Retirement System (OPERS)
32
Ohio Public Employees Retirement System (OPERS)
Ohio
$517K
Connor, Clark & Lunn Investment Management (CC&L)
33
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$488K -$169K -20,300 -24%
Federated Hermes
34
Federated Hermes
Pennsylvania
$479K -$388K -46,620 -42%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$466K
Bank of America
36
Bank of America
North Carolina
$424K +$93.3K +11,223 +24%
Los Angeles Capital Management
37
Los Angeles Capital Management
California
$414K +$464K +55,780 New
BPC
38
Banque Pictet & Cie
Switzerland
$402K
BCM
39
Bridgeway Capital Management
Texas
$394K +$5.4K +650 +1%
CAM
40
ClariVest Asset Management
California
$371K +$69.8K +8,400 +20%
BBA
41
Baker Bros. Advisors
New York
$364K
Citadel Advisors
42
Citadel Advisors
Florida
$344K +$282K +33,871 +271%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$317K +$47.1K +5,664 +15%
TA
44
Teachers Advisors
New York
$311K
KeyBank National Association
45
KeyBank National Association
Ohio
$300K -$121K -14,544 -26%
California State Teachers Retirement System (CalSTRS)
46
California State Teachers Retirement System (CalSTRS)
California
$283K -$42.9K -5,158 -12%
AllianceBernstein
47
AllianceBernstein
Tennessee
$278K -$1.02M -122,187 -77%
American Century Companies
48
American Century Companies
Missouri
$267K -$45.3K -5,451 -13%
Charles Schwab
49
Charles Schwab
California
$262K -$188K -22,600 -39%
Wells Fargo
50
Wells Fargo
California
$255K +$90.7K +10,908 +46%

CCXI Hedge Fund Activity: Q3 2017 in Review

86 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2017, worth a combined $177M — down 23% from $228M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CCXI and 12 opened new positions — a net loss of 2 holders — while 24 trimmed existing stakes and 31 added.

The largest buyer was BlackRock, adding an estimated $3.69M. The largest seller was BVF Inc, cutting an estimated $5.49M.

  • 86 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2017, down from 88 in Q2 2017.
  • Funds reported $177M of ChemoCentryx, Inc. stock for Q3 2017, down 23% quarter-over-quarter.
  • 12 funds opened new ChemoCentryx, Inc. positions in Q3 2017 and 14 closed out, a net change of -2 holders.
  • The largest ChemoCentryx, Inc. buyer in Q3 2017 was BlackRock, an estimated $3.69M added.
  • The largest ChemoCentryx, Inc. seller in Q3 2017 was BVF Inc, an estimated $5.49M sold.

Based on aggregated 13F filings for Q3 2017.